Welcome to Multibagg AI
Log in to access personalized features
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Investor Presentation
Q1 FY22
Investor Presentation
Q3 FY21
Bearish
3
Neutral
6
Bullish
5
Bearish
25
Neutral
6
Bullish
15
Bearish
22
Neutral
0
Bullish
10
Discovery themes featuring this stock
Lotus Eye Hospital & Institute Ltd is a renowned eye care hospital group situated in South India, specializing in super-specialty services related to ophthalmology.
The company operates seven centers across major cities, offering advanced eye care through cutting-edge technologies like LASIK and Zyoptix, backed by expert ophthalmologists.
Lotus Eye Hospital was the first in South East Asia to implement Epilasik technology and has consistently introduced advanced ophthalmic procedures.
It maintains a total bed capacity of 120 across its centers, focusing predominantly on outpatient and day-care surgeries.
The hospital's operations are characterized by high-tech equipments, ensuring top-tier eye care with a well-trained paramedical and administrative workforce.
Healthcare
Hospitals / Medical Services
226 Cr
Low Risk
370.8
60.2
—
3.7
147.60
55.95
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Lotus Eye Hospital & Institute Ltd (LOTUSEYE) is currently trading at 110.95 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Lotus Eye Hospital & Institute Ltd is a renowned eye care hospital group situated in South India, specializing in super-specialty services related to ophthalmology. The company operates seven centers across major cities, offering advanced eye care through cutting-edge technologies like LASIK and Zyoptix, backed by expert ophthalmologists. Lotus Eye Hospital was the first in South East Asia to implement Epilasik technology and has consistently introduced advanced ophthalmic procedures. It maintains a total bed capacity of 120 across its centers, focusing predominantly on outpatient and day-care surgeries. The hospital's operations are characterized by high-tech equipments, ensuring top-tier eye care with a well-trained paramedical and administrative workforce.
Over the past 52 weeks, Lotus Eye Hospital & Institute Ltd has traded between a low of ₹55.95 and a high of ₹147.60. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Lotus Eye Hospital & Institute Ltd has a market capitalization of approximately 225.95. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Lotus Eye Hospital & Institute Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 370.75 and operates in the Healthcare sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 225.95 Cr, Lotus Eye Hospital & Institute Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Lotus Eye Hospital & Institute Ltd operates in the Healthcare sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Lotus Eye Hospital & Institute Ltd is 370.75. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
162.00 | 315 Cr | 19.52 | 3.36 | 0.00 | 17.42 | 18.42 | 7.89 | |
110.95 | 226 Cr | 370.75 | 3.73 | 0.00 | 1.11 | 2.57 | 0.91 | |
77.00 | 180 Cr | 55.00 | 1.81 | 0.00 | 1.13 | 2.34 | 2.08 | |
186.00 | 129 Cr | 21.16 | 4.84 | 0.00 | 0.52 | 4.98 | 0.33 | |
73.60 | 121 Cr | 30.92 | 2.25 | 0.00 | 6.13 | 8.59 | 5.07 | |
52.08 | 100 Cr | 21.43 | 2.91 | 0.00 | 13.19 | 14.48 | 12.21 |
